Details for New Drug Application (NDA): 218527
✉ Email this page to a colleague
NDA 218527 describes CHEWTADZY, which is a drug marketed by B Better and is included in one NDA. Additional details are available on the CHEWTADZY profile page.
The generic ingredient in CHEWTADZY is tadalafil. There are twenty-five drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the tadalafil profile page.
The generic ingredient in CHEWTADZY is tadalafil. There are twenty-five drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the tadalafil profile page.
Medical Subject Heading (MeSH) Categories for 218527
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 5MG | ||||
| Approval Date: | Jun 28, 2024 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 10MG | ||||
| Approval Date: | Jun 28, 2024 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 20MG | ||||
| Approval Date: | Jun 28, 2024 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
